D-serine adjuvant treatment alleviates behavioural and motor symptoms in Parkinson's disease.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/21733283
Conclusion of this study
DSR treatment was well tolerated and resulted in increased DSR serum levels (p=0.001) and significantly reduced UPDRS (p=0.02), SAS (p=0.009) and PANSS (0.05) total scores. These preliminary findings suggest that DSR treatment may be beneficial in PD. Larger-sized studies with optimized DSR dosages are warranted.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study